2021 journal article

Serum nitrite and nitrate: A potential biomarker for post-covid-19 complications

FREE RADICAL BIOLOGY AND MEDICINE, 175, 216–225.

By: J. Wang*, F. Mei*, L. Bai*, S. Zhou*, D. Liu*, L. Yao*, A. Ahluwalia*, R. Ghiladi n ...

co-author countries: China 🇨🇳 United Kingdom of Great Britain and Northern Ireland 🇬🇧 United States of America 🇺🇸
author keywords: COVID-19; Nitric oxide; Nitrite; Nitrate; Biomarker; Long-term effect
MeSH headings : Adult; Aged; Biomarkers; COVID-19; Humans; Nitrates; Nitric Oxide; Nitrites; SARS-CoV-2
Source: Web Of Science
Added: October 12, 2021

Nitric oxide (NO) plays an important role in cardiovascular and immune systems. Quantification of blood nitrite and nitrate, two relatively stable metabolites of NO (generally as NOx), has been acknowledged, in part, representing NO bioactivity. Dysregulation of NOx had been reported in SARS-CoV-2 infected populations, but whether patients recovered from COVID-19 disease present with restored NOx is unknown. In this study, serum NO2- and NO3- were quantified and analyzed among 109 recovered adults in comparison to a control group of 166 uninfected adults. Nitrite or nitrate levels were not significantly different among mild-, common-, severe- and critical-type patients. However, these recovered patients had dramatically lower NO2- and NO2-/NO3- than the uninfected group (p < 0.0001), with significantly higher NO3- levels (p = 0.0023) than the uninfected group. Nitrate and nitrite/nitrate were positively and negatively correlated with patient age, respectively, with age 65 being a turning point among recovered patients. These results indicate that low NO2-, low NO2-/NO3- and high NO3- may be potential biomarkers of long-term poor or irreversible outcomes after SARS-CoV-2 infection. It suggests that NO metabolites might serve as a predictor to track the health status of recovered COVID-19 patients, highlighting the need to elucidate the role of NO after SARS-CoV-2 infection.